Lavka OÜRegistered
Key figures
367 589 €−0,8%
Revenue 2025
+10,6%
Average annual growth 2019–2025
Ratios
20250,4%
Profit margin
0,4%
EBITDA margin
24,4%
Equity ratio
2,2×
Current ratio
6,7%
Return on equity
1064 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 117 029 € | — | 5252 € |
| Q1 2026 | 103 580 € | 5 | 5039 € |
| Q4 2025 | 118 542 € | 5 | 3313 € |
| Q3 2025 | 41 124 € | 5 | 1837 € |
| Q2 2025 | 108 640 € | — | 5347 € |
| Q1 2025 | 99 250 € | 5 | 5187 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 42 009 | 21 685 | 59 652 | 67 822 | 75 329 | 59 179 | 57 301 |
| Total non-current assets | 8038 | 42 728 | 32 601 | 29 404 | 44 875 | 41 311 | 41 311 |
| Total assets | 50 047 | 64 413 | 92 253 | 97 226 | 120 204 | 100 490 | 98 612 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 26 741 | 39 866 | 52 015 | 55 188 | 76 916 | 78 014 | 26 470 |
| Non-current liabilities | 0 | 0 | — | — | — | — | 48 061 |
| Total liabilities | 26 741 | 39 866 | 52 015 | 55 188 | 76 916 | 78 014 | 74 531 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | 19 202 | 20 556 | 21 797 | 37 488 | 39 288 | 40 538 | 19 726 |
| Profit for the year | 1354 | 1241 | 15 691 | 1800 | 1250 | −20 812 | 1605 |
| Reserves and other equity | 250 | 250 | 250 | 250 | 250 | 250 | 250 |
| Total equity | 23 306 | 24 547 | 40 238 | 42 038 | 43 288 | 22 476 | 24 081 |
| Income statement | |||||||
| Sales revenue | 201 175 | 156 686 | 307 790 | 267 768 | 350 027 | 370 735 | 367 589 |
| Operating profit | 1437 | 1263 | 15 691 | 1800 | 1250 | −20 813 | 1605 |
| EBITDA | 4292 | 2933 | 25 818 | 4997 | 3579 | −17 249 | 1605 |
| Profit before income tax | 1354 | 1241 | 15 691 | 1800 | 1250 | −20 812 | 1605 |
| Profit for the reporting year | 1354 | 1241 | 15 691 | 1800 | 1250 | −20 812 | 1605 |
| Labour costs | 62 822 | 44 842 | 54 648 | 69 802 | 58 840 | 54 084 | 51 264 |
| Depreciation of non-current assets | 2855 | 1670 | 10 127 | 3197 | 2329 | 3564 | 0 |
| Other indicators | |||||||
| Employees | 7 | 6 | 7 | 6 | 5 | 4 | 3 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Lepinguline toitlustusteenus jm toitlustamine